Monoclonal Mouse anti‑Human PARVA Antibody (clone OTI2F9, Carrier‑free, IHC, IF, WB) LS‑C797709
Monoclonal Mouse anti‑Human PARVA Antibody (clone OTI2F9, Carrier‑free, IHC, IF, WB) LS‑C797709
Antibody:
PARVA Mouse anti-Human Monoclonal (Carrier-free) (OTI2F9) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
PARVA Mouse anti-Human Monoclonal (Carrier-free) (OTI2F9) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
PARVA antibody LS-C797709 is an unconjugated mouse monoclonal antibody to human PARVA. Validated for IF, IHC and WB.
Target
Human PARVA
Synonyms
PARVA | Actopaxin | Alpha-parvin | CH-ILKBP | Parvin, alpha | MXRA2
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Full length human recombinant protein of human PARVA(NP_060692) produced in HEK293T cell.
Applications
- IHC (1:150)
- Immunofluorescence (1:100)
- Western blot (1:4000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Monkey, Mouse, Rat, Dog
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 1/9/2025